首页 | 本学科首页   官方微博 | 高级检索  
     


Mitral annular calcification and the serum osteocalcin level in patients with chronic kidney disease
Authors:Hilmi Umut Unal  Murat Çelik  Yalçın Gökoğlan  Hakkı Çetinkaya  Mahmut Gök  Murat Karaman
Affiliation:1. Department of Nephrology;2. Department of Cardiology, Gülhane Military Medical AcademyAnkaraTurkey
Abstract:Objective: To determine the relationships between inflammatory mediators, mitral annular calcification (MAC), and osteocalcin in patients with chronic kidney disease (CKD). Materials and methods: Echocardiographic data for 60 patients diagnosed as CKD were retrospectively evaluated. The patients were divided into 2 groups; patients with MAC (MAC+ group) and patients without MAC (MAC? group). The relationships between biochemical markers—including osteocalcin—and MAC were evaluated. Results: The study included 19 female and 41 male patients. In all, 29 patients were MAC+ and 31 were MAC?. High-sensitive C-reactive protein (hsCRP) and osteocalcin levels were significantly higher in the MAC+ group (p?0.05). The eGFR was lower, serum calcitonin (we could not obtain calcitonin data for 15 patients), Ca, PO4, CaxPO4, the erythrocyte sedimentation rate, red cell distribution width, the neutrophil/Lymphocyte rate, and PTH were higher in the MAC+ group; however, the differences between the groups were not significant (p?>?0.05). The mitral E/A ratio, mitral peak Ea velocity, tricuspid E/A ratio, hsCRP, and the osteocalcin level were strongly correlated with MAC. Multivariate logistic regression analysis showed that only the osteocalcin level and mitral E/A ratio were independent variables, each with an independent effect on MAC. Conclusion: CKD patients in the MAC+ group had higher osteocalcin levels than those in the MAC? group, and left ventricular diastolic dysfunction was more common in the MAC+ group.
Keywords:Chronic kidney disease echocardiography  mitral annular calcification  osteocalcin
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号